Kelly Financial Services LLC Seres Therapeutics, Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024
SELL
$5.46 - $22.6 $29,942 - $123,938
-5,484 Reduced 95.81%
240 $1.67 Million
Q2 2021

Jul 17, 2024
BUY
$18.46 - $24.36 $101,234 - $133,590
5,484 Added 2285.0%
5,724 $240,000
Q4 2020

Jul 17, 2024
BUY
$23.25 - $37.73 $3,255 - $5,282
140 Added 140.0%
240 $5.88 Million
Q2 2020

Jul 17, 2024
BUY
$3.04 - $6.2 $304 - $620
100 New
100 $476,000

Others Institutions Holding MCRB

# of Institutions
92
Shares Held
46.6M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $85.6M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email